TABLE 1.
Mean value and standard deviation (SD) of increase in root length (mm) and the percentage of increase in all groups
| Groups |
Subgroup A (1 mo) |
Subgroup B (2 mo) |
Subgroup C (3 mo) |
P‐value | |||
|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | ||
|
Group I (blood clot) |
0.98aA (9.7%) |
0.08 |
1.21bA (12.8%) |
0.04 |
1.88cA (17.3%) |
0.10 | ≤.001* |
|
Group II (EDTA + blood clot) |
1.09aB (10.1%) |
0.06 |
1.34bB (14.1%) |
0.04 |
1.90cAB (18.2%) |
0.12 | ≤.001* |
|
Group III (PRF) |
1.20aC (11.3%) |
0.03 |
1.50bC (15.8%) |
0.06 |
1.95cAB (18.6%) |
0.07 | ≤.001* |
|
Group IV (EDTA + PRF) |
1.21aC (11.4%) |
0.07 |
1.58bD (16.6%) |
0.07 |
1.97cB (18.9%) |
0.08 | ≤.001* |
|
Group V (positive control) |
0.00 ( 0%) |
0.00 (0%) |
0.00 (0%) |
||||
|
Group VI (negative control) |
1.31aD (13.2%) |
0.08 |
1.77bE (17.8%) |
0.12 |
2.10cC (20.1%) |
0.12 | ≤.001* |
| P‐value | ≤.001* | ≤.001* | ≤.001* | ||||
The same upper‐case letters within each column indicate insignificant difference.
The same lower‐case letters within each row indicate insignificant difference.
Abbreviation: NS, non‐significant.
*
Significant at P ≤ .05.